CLINICAL_TRIALS
trial_result
· 2022-12-16
Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of CEP-33457 in Participants With Systemic Lupus Erythematosus (SLE) [Phase 2]
Summary
Phase 2 trial evaluating CEP-33457 for efficacy and safety in systemic lupus erythematosus has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cephalon, Inc. | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: COMPLETED | Results posted: 2022-12-16